Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. That said, here is one stock where you should be greedy instead of fearful and two facing legitimate challenges.
Two Stocks to Sell:
RE/MAX (RMAX)
Consensus Price Target: $11.40 (-10.8% implied return)
Short for Real Estate Maximums, RE/MAX (NYSE:RMAX) operates a real estate franchise network spanning over 100 countries and territories.
Why Is RMAX Risky?
- Number of agents has disappointed over the past two years, indicating weak demand for its offerings
- Poor free cash flow margin of 10.1% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends
- Returns on capital are increasing as management makes relatively better investment decisions
RE/MAX is trading at $12.78 per share, or 9.3x forward P/E. Read our free research report to see why you should think twice about including RMAX in your portfolio.
Illumina (ILMN)
Consensus Price Target: $198.89 (5.2% implied return)
Pioneering the ability to read the human genome at unprecedented speed and affordability, Illumina (NASDAQ:ILMN) develops and sells advanced DNA sequencing and microarray technologies that allow researchers and clinicians to analyze genetic variations and functions.
Why Does ILMN Give Us Pause?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Revenue growth over the past five years was nullified by the company’s new share issuances as its earnings per share fell by 3% annually
- Push for growth has led to negative returns on capital, signaling value destruction
Illumina’s stock price of $189.12 implies a valuation ratio of 33.8x forward P/E. To fully understand why you should be careful with ILMN, check out our full research report (it’s free).
One Stock to Watch:
RTX (RTX)
Consensus Price Target: $232.27 (4.5% implied return)
Originally focused on refrigeration technology, Raytheon (NSYE:RTX) provides a variety of products and services to the aerospace and defense industries.
Why Should RTX Be on Your Watchlist?
- Core business is healthy and doesn’t need acquisitions to boost sales as its organic revenue growth averaged 10.5% over the past two years
- Share repurchases over the last five years enabled its annual earnings per share growth of 16.3% to outpace its revenue gains
- Free cash flow margin grew by 5.2 percentage points over the last five years, giving the company more chips to play with
At $222.31 per share, RTX trades at 29.9x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.